Inventor · disambiguated record
Shibo Jiang
Also filed as: JIANG SHIBO
29 granted patents·9 pending applications·406 citations·filing 1991–2024
96Inventor score
Files withNEW YORK BLOOD CENTER INC13JIANG SHIBO7NEW YORK BLOOD CT INC7FULGENT GENETICS INC2SHANXI JINBO BIO PHARMACEUTICAL CO LTD2
Top patents by PatentIndex Score
38 records- 0195US6596497B1Screening of antiviral compounds targeted to the HIV-1 gp41 core structureNEW YORK BLOOD CT INC·Filed 2000·Granted Jul 22, 2003·63 cites·4 claims
- 0288US6165493A"Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"NEW YORK BLOOD CT INC·Filed 1998·Granted Dec 26, 2000·77 cites·45 claims
- 0387US9889194B2Immunogenic composition for MERS coronavirus infectionNEW YORK BLOOD CENTER INC·Filed 2014·Granted Feb 13, 2018·12 cites·23 claims
- 0483US5840843ASynthetic polypeptides as inhibitors of HIV-1NEW YORK BLOOD CENTER INC·Filed 1995·Granted Nov 24, 1998·40 cites·37 claims
- 0581US5444044ASynthetic polypeptides as inhibitors of HIV-1NEW YORK BLOOD CENTER INC·Filed 1992·Granted Aug 22, 1995·48 cites·20 claims
- 0678US8900585B2Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infectionJIANG SHIBO·Filed 2011·Granted Dec 2, 2014·2 cites·6 claims
- 0778US8828931B2Bifunctional molecules for inhibiting HIV entryJIANG SHIBO·Filed 2009·Granted Sep 9, 2014·3 cites·16 claims
- 0876US8936789B2Immunoenhancer-linked oligomeric HIV envelope peptidesJIANG SHIBO·Filed 2009·Granted Jan 20, 2015·3 cites·15 claims
- 0976US7629443B2Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirusNEW YORK BLOOD CT INC·Filed 2006·Granted Dec 8, 2009·3 cites·1 claims
- 1075US9701736B2Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infectionNEW YORK BLOOD CENTER INC·Filed 2014·Granted Jul 11, 2017·1 cites·6 claims
- 1173US9115186B2Stabilized trimeric HIV-1 gp41 fusion polypeptides comprising the N-terminal heptad repeat (NHR) and foldon (FD) trimerization motifJIANG SHIBO·Filed 2010·Granted Aug 25, 2015·1 cites·4 claims
- 1272US7241803B2Compounds for inhibition of HIV infection by blocking HIV entryNEW YORK BLOOD CT INC·Filed 2003·Granted Jul 10, 2007·4 cites·26 claims
- 1372US5985275Aβ-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infectionNEW YORK BLOOD CENTER INC·Filed 1995·Granted Nov 16, 1999·22 cites·17 claims
- 1471US2025108106A1Nanoencapsulated pharmaceutical composition and use thereofFULGENT GENETICS INC·Filed 2024·Application pending·0 cites
- 1570US5230998AMethod for the prescreening of drugs targeted to the V3 hypervariable loop of the HIV-1 envelope glycoprotein gp 120NEURATH ALEXANDER R·Filed 1991·Granted Jul 27, 1993·43 cites·7 claims
- 1669US11999806B2Broad-spectrum polypeptide against enterovirus and application thereofWUHAN INST VIROLOGY CAS·Filed 2019·Granted Jun 4, 2024·1 cites·9 claims
- 1766US8933106B22-(4-substituted phenylamino) polysubstituted pyridine compounds as inhibitors of non-nucleoside HIV reverse transcriptase, preparation methods and uses thereofXIE LAN·Filed 2009·Granted Jan 13, 2015·1 cites·16 claims
- 1865US12351604B2Fusion protein and use thereofSHANXI JINBO BIO PHARMACEUTICAL CO LTD·Filed 2023·Granted Jul 8, 2025·0 cites·13 claims
- 1965US5985313AMethod for decreasing the frequency of transmission of viral infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipientsNEW YORK BLOOD CENTER INC·Filed 1998·Granted Nov 16, 1999·26 cites·32 claims
- 2061US7919101B2Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitorsNEW YORK BLOOD CT INC·Filed 2009·Granted Apr 5, 2011·0 cites·10 claims
- 2160US5952009AMethods for preventing the transmission of or treating patients infected with herpesvirusNEW YORK BLOOD CENTER INC·Filed 1996·Granted Sep 14, 1999·21 cites·11 claims
- 2260US5798206AMethods for screening of test compounds for inhibiting binding of a CD4-HIV 1 complex to a chemokine receptorNEW YORK BLOOD CENTER INC·Filed 1997·Granted Aug 25, 1998·25 cites·17 claims
- 2360US2007232684A1Compounds for inhibition of HIV infection by blocking HIV entryNEW YORK BLOOD CT INC·Filed 2007·Application pending·0 cites
- 2459US9943589B2Immunopotentiator-linked oligomeric influenza immunogenic compositionsNEW YORK BLOOD CENTER INC·Filed 2017·Granted Apr 17, 2018·0 cites·8 claims
- 2555US9592287B2Immunopotentiator-linked oligomeric influenza immunogenic compositionsJIANG SHIBO·Filed 2010·Granted Mar 14, 2017·0 cites·8 claims
- 2653US11103575B2Immunogenic composition for MERS coronavirus infectionNEW YORK BLOOD CENTER INC·Filed 2017·Granted Aug 31, 2021·0 cites·20 claims
- 2753US9724383B2Stabilized trimeric HIV-1 GP41 fusion inhibitor polypeptides comprising the N-terminal heptad repeat (NHR) and foldon (FD) trimerization motifNEW YORK BLOOD CENTER INC·Filed 2015·Granted Aug 8, 2017·0 cites·4 claims
- 2853US2024002383A1Compounds and their use as vaccine adjuvantsFULGENT GENETICS INC·Filed 2023·Application pending·0 cites
- 2951US2022313651A1Inhibitors of zika virus infectionNEW YORK BLOOD CENTER INC·Filed 2020·Application pending·0 cites
- 3049US8309602B2Multi-substituted diarylanilines as non-nucleoside HIV reverse transcriptase inhibitors, and preparation and use thereofXIE LAN·Filed 2008·Granted Nov 13, 2012·0 cites·11 claims
- 3149US2023346916A1Immunogenic compositions against severe acute respiratory syndrome coronavirus 2NEW YORK BLOOD CENTER INC·Filed 2021·Application pending·0 cites
- 3249US2010021427A1Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIVTIANJIN FUSOGEN PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 3347US2022409694A1Polypeptide, and preparation method therefor and use thereofSHANXI JINBO BIO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3445US12152017B2Ketoamide compound and preparation method, pharmaceutical composition, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Nov 26, 2024·0 cites·10 claims
- 3545US8828932B2Bifunctional molecules for inactivating HIV and blocking HIV entryJIANG SHIBO·Filed 2011·Granted Sep 9, 2014·0 cites·3 claims
- 3645US6727240B1Methods for preventing HIV-1 or HIV-2 infectionNEW YORK BLOOD CT INC·Filed 1994·Granted Apr 27, 2004·10 cites·12 claims
- 3743US2006287319A1Anti-viral compositions comprising heterocyclic substituted phenyl furans and related compoundsJIANG SHIBO·Filed 2006·Application pending·0 cites
- 3843US2016000900A1Oligomeric influenza immunogenic compositionsFUTUREWEI TECHNOLOGIES INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shibo Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →